Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,617 across all filing types
Latest filing 2022-11-09 Audit Report / Informat…
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
111年第3季財務報告書 — 202204_3164_AI3.pdf
Audit Report / Information Classification · 95% confidence The document is titled as an individual financial report and auditor's report for the fiscal years 111 and 110 (Taiwanese calendar years corresponding to 2022 and 2021). It contains detailed financial statements including balance sheets, income statements, statements of changes in equity, cash flow statements, and extensive notes on accounting policies and estimates. The presence of an auditor's opinion and detailed audit procedures indicates this is a full audit report accompanying the financial statements. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Audit Report / Information (AR) rather than a full Annual Report (10-K) or other categories. The focus is on the audit opinion and related financial statements for the individual entity, consistent with the AR category. FY 2022
2022-11-09 Chinese
111年第3季財務報告書 — 202204_3164_AI1.pdf
Annual Report Classification · 100% confidence The document is titled as a consolidated financial report and auditor's report for the fiscal years 111 and 110 (Taiwanese calendar years). It includes detailed financial statements such as consolidated balance sheets, income statements, cash flow statements, and notes to the financial statements. There is a clear auditor's opinion section, key audit matters, and management responsibilities related to the consolidated financial report. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not just an announcement or certification. The presence of the auditor's report integrated with the financial statements indicates this is a full annual report rather than a standalone audit report. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2022-11-09 Chinese
111年第3季財務報告書 — 202203_3164_AI1.pdf
Regulatory Filings
2022-11-09 Chinese
111年第3季財務報告書 — 202202_3164_AI1.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled as a consolidated financial report and accountant's review report for the second quarter of the years 111 and 110 (using the Taiwanese calendar, corresponding to 2022 and 2021). It includes a detailed table of contents listing consolidated balance sheets, income statements, cash flow statements, notes to financial statements, and an accountant's review report. The presence of an accountant's review report (核閱報告) and the reference to International Accounting Standard 34 (Interim Financial Reporting) indicates this is a mid-year financial report. The document contains actual financial statements and detailed notes, not just an announcement or certification. The length is substantial (15,000 characters), and the content matches the characteristics of an Interim / Quarterly Report rather than a full Annual Report or just an audit report. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2022
2022-11-09 Chinese
111年第3季財務報告書 — 202201_3164_AI1.pdf
Regulatory Filings
2022-11-09 Chinese
111年第3季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial data specifically a consolidated statement of changes in equity for the first three quarters of the fiscal year 111 (which corresponds to 2022 in the ROC calendar). It includes line items such as ordinary share capital, capital surplus, legal reserve, special reserve, undistributed earnings, and total equity. The data is presented in a tabular format with comparative figures for the previous year. The document length is 4268 characters, which is relatively short but contains substantive financial data rather than just an announcement or a link to a report. The content is consistent with an Interim / Quarterly Report (IR) because it covers a period shorter than a full fiscal year and includes actual financial statements and analysis. There is no indication that this is a full Annual Report (10-K) or just an announcement. Therefore, the classification is Interim / Quarterly Report (IR). 9M 2022
2022-11-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.